no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection
|
Martina, Byron E.E. |
|
2001 |
20 |
5-6 |
p. 943-948 6 p. |
article |
2 |
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers
|
Pitisuttithum, Punnee |
|
2001 |
20 |
5-6 |
p. 920-925 6 p. |
article |
3 |
Anthrax vaccine: short-term safety experience in humans
|
Pittman, Phillip R |
|
2001 |
20 |
5-6 |
p. 972-978 7 p. |
article |
4 |
Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism
|
Hisaeda, Hajime |
|
2001 |
20 |
5-6 |
p. 763-770 8 p. |
article |
5 |
Cold-attenuated live influenza vaccines, a risk-benefit assessment
|
Pfleiderer, Michael |
|
2001 |
20 |
5-6 |
p. 886-894 9 p. |
article |
6 |
Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate
|
Milich, David R |
|
2001 |
20 |
5-6 |
p. 771-788 18 p. |
article |
7 |
Corrigendum to “Reactogenicity and immunogenicity of adult versus paediatric diptheria and tetanus booster dose at 6 years of age” [Vaccine 20 (2002) 74–79]
|
Ciofi degli Atti, M.L. |
|
2001 |
20 |
5-6 |
p. 989- 1 p. |
article |
8 |
Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B′ strains by recombinant Mycobacterium bovis BCG-based candidate vaccine
|
Chujoh, Yoshitomo |
|
2001 |
20 |
5-6 |
p. 797-804 8 p. |
article |
9 |
Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications
|
Hilleman, Maurice R |
|
2001 |
20 |
5-6 |
p. 651-665 15 p. |
article |
10 |
Effect of influenza immunization on CYP3A4 activity
|
Hayney, Mary S. |
|
2001 |
20 |
5-6 |
p. 858-861 4 p. |
article |
11 |
Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3)
|
Shankar, Pragyna |
|
2001 |
20 |
5-6 |
p. 744-755 12 p. |
article |
12 |
Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector
|
Gómez, Carmen Elena |
|
2001 |
20 |
5-6 |
p. 961-971 11 p. |
article |
13 |
Erratum to “Developing Country Vaccine Manufacturers Network (DCVMN), 26–27 April 2001, Bandung, Indonesia” [Vaccine 20 (2002) 285–287]
|
Poeloengan, Thamrin |
|
2001 |
20 |
5-6 |
p. 990- 1 p. |
article |
14 |
Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice
|
da Cruz, Flávia W. |
|
2001 |
20 |
5-6 |
p. 731-736 6 p. |
article |
15 |
Frequent occurrence of hepatitis B virus surface antigen mutants in subtype adw in vaccinated Singapore infants
|
Chen, Wei Ning |
|
2001 |
20 |
5-6 |
p. 639-640 2 p. |
article |
16 |
Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin
|
Ohmura, Mari |
|
2001 |
20 |
5-6 |
p. 756-762 7 p. |
article |
17 |
Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum
|
Zheng, Chunfu |
|
2001 |
20 |
5-6 |
p. 914-919 6 p. |
article |
18 |
Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis
|
Crocquet-Valdes, P.A |
|
2001 |
20 |
5-6 |
p. 979-988 10 p. |
article |
19 |
Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells
|
Zhang, Mingdong |
|
2001 |
20 |
5-6 |
p. 853-857 5 p. |
article |
20 |
Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals
|
Dieye, Tandakha Ndiaye |
|
2001 |
20 |
5-6 |
p. 905-913 9 p. |
article |
21 |
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein
|
Moriya, Osamu |
|
2001 |
20 |
5-6 |
p. 789-796 8 p. |
article |
22 |
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation
|
Munoz, Flor M. |
|
2001 |
20 |
5-6 |
p. 826-837 12 p. |
article |
23 |
Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials
|
Okoko, Brown J |
|
2001 |
20 |
5-6 |
p. 647-650 4 p. |
article |
24 |
One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination
|
Lodmell, Donald L. |
|
2001 |
20 |
5-6 |
p. 838-844 7 p. |
article |
25 |
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy
|
Liu, Wen Jun |
|
2001 |
20 |
5-6 |
p. 862-869 8 p. |
article |
26 |
ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid
|
Julie Westerink, M.A |
|
2001 |
20 |
5-6 |
p. 711-723 13 p. |
article |
27 |
Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model
|
Nehete, Pramod N |
|
2001 |
20 |
5-6 |
p. 813-825 13 p. |
article |
28 |
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
|
Wu, Cheng-Nan |
|
2001 |
20 |
5-6 |
p. 895-904 10 p. |
article |
29 |
PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae
|
Miyaji, Eliane N. |
|
2001 |
20 |
5-6 |
p. 805-812 8 p. |
article |
30 |
Quantifying the population impact of a prophylactic Helicobacter pylori vaccine
|
Rupnow, Marcia F.T. |
|
2001 |
20 |
5-6 |
p. 879-885 7 p. |
article |
31 |
Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes
|
McManus, Donald P. |
|
2001 |
20 |
5-6 |
p. 870-878 9 p. |
article |
32 |
Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration
|
Campins-Martı́, M. |
|
2001 |
20 |
5-6 |
p. 641-646 6 p. |
article |
33 |
Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines
|
Simoes, Eric A.F |
|
2001 |
20 |
5-6 |
p. 954-960 7 p. |
article |
34 |
Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers
|
Bumann, D |
|
2001 |
20 |
5-6 |
p. 845-852 8 p. |
article |
35 |
Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL®) adjuvant: a new allergy vaccine for dust mite allergy
|
Baldrick, Paul |
|
2001 |
20 |
5-6 |
p. 737-743 7 p. |
article |
36 |
T-cell vaccination for autoimmune disease: a panorama
|
Cohen, Irun R. |
|
2001 |
20 |
5-6 |
p. 706-710 5 p. |
article |
37 |
Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis
|
Reveneau, Nathalie |
|
2001 |
20 |
5-6 |
p. 926-933 8 p. |
article |
38 |
The basis for HIV immunotherapeutic vaccines
|
Peters, B.S. |
|
2001 |
20 |
5-6 |
p. 688-705 18 p. |
article |
39 |
The costs of an outbreak—an example from a Danish day care setting
|
Fischer, T.K. |
|
2001 |
20 |
5-6 |
p. 637-638 2 p. |
article |
40 |
The frailty hypothesis revisited: mainly weak children die of measles
|
Aaby, Peter |
|
2001 |
20 |
5-6 |
p. 949-953 5 p. |
article |
41 |
Use of fusion protein constructs to generate potent immunotherapy and protection against scorpion toxins
|
Legros, Christian |
|
2001 |
20 |
5-6 |
p. 934-942 9 p. |
article |
42 |
Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection
|
Zhang, Yaobi |
|
2001 |
20 |
5-6 |
p. 724-730 7 p. |
article |
43 |
Vaccine prevention of meningococcal disease, coming soon?
|
Morley, Sarah L. |
|
2001 |
20 |
5-6 |
p. 666-687 22 p. |
article |